JAIME KUTTER: Open Payments
NPI 1831247501 · ALPHARETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,164 in 53 payments from 18 companies in 2025. Trend: 2023 $1,159 · 2024 $947 · 2025 $1,164
Food & beverage: $1,164
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $198 |
| ABBVIE INC. | 12 | $135 |
| Amgen Inc. | 3 | $124 |
| AstraZeneca Pharmaceuticals LP | 6 | $114 |
| PFIZER INC. | 4 | $96 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $73 |
| GlaxoSmithKline, LLC. | 4 | $68 |
| Dexcom, Inc. | 2 | $68 |
| Janssen Pharmaceuticals, Inc | 2 | $57 |
| Astellas Pharma US Inc | 2 | $40 |
Products named: Wegovy, KRYSTEXXA, CAPLYTA, Dexcom G6 Transmitter, QULIPTA, Ozempic, AIRSUPRA, SPRAVATO.
Industry payments across GA — which companies pay providers there.
